Nicolas Bovy

1.2k total citations
10 papers, 853 citations indexed

About

Nicolas Bovy is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Nicolas Bovy has authored 10 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Nicolas Bovy's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers) and Circular RNAs in diseases (4 papers). Nicolas Bovy is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers) and Circular RNAs in diseases (4 papers). Nicolas Bovy collaborates with scholars based in Belgium, Germany and Spain. Nicolas Bovy's co-authors include Ingrid Struman, Joseph Martial, Agnès Noël, Sébastien P. Tabruyn, Guy Jérusalem, Claire Josse, Pierre Frères, Vincent Bours, Ludovic Malvaux and Alain Colige and has published in prestigious journals such as PLoS ONE, Journal of Cellular Physiology and European Journal of Cancer.

In The Last Decade

Nicolas Bovy

10 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas Bovy Belgium	9	508	453	228	215	57	10	853
Ludovic Malvaux Belgium	6	414 0.8×	318 0.7×	215 0.9×	149 0.7×	20 0.4×	7	671
Ngoc-Quynh-Nhu Nguyen Belgium	8	338 0.7×	216 0.5×	237 1.0×	147 0.7×	43 0.8×	8	607
Selina Vergel United States	10	219 0.4×	144 0.3×	104 0.5×	241 1.1×	35 0.6×	10	592
Maria Cristina Carena Italy	8	696 1.4×	627 1.4×	162 0.7×	90 0.4×	23 0.4×	11	976
Mathilde Lemitre France	11	362 0.7×	108 0.2×	171 0.8×	192 0.9×	51 0.9×	15	685
Barry Fine United States	11	389 0.8×	106 0.2×	94 0.4×	181 0.8×	97 1.7×	26	686
Ilpo Koskivirta Finland	6	342 0.7×	185 0.4×	84 0.4×	58 0.3×	223 3.9×	7	618
M. Crowther United Kingdom	10	176 0.3×	187 0.4×	95 0.4×	228 1.1×	127 2.2×	14	768
Wei‐Lun Hwang Taiwan	15	503 1.0×	330 0.7×	42 0.2×	71 0.3×	344 6.0×	29	898

Countries citing papers authored by Nicolas Bovy

Since Specialization

Citations

This map shows the geographic impact of Nicolas Bovy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Bovy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Bovy more than expected).

Fields of papers citing papers by Nicolas Bovy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Bovy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Bovy. The network helps show where Nicolas Bovy may publish in the future.

Co-authorship network of co-authors of Nicolas Bovy

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Bovy. A scholar is included among the top collaborators of Nicolas Bovy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Bovy. Nicolas Bovy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Rampelbergh, Jean Van, Peter Achenbach, Richard David Leslie, et al.. (2024). First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers. BMC Medicine. 22(1). 259–259. 10 indexed citations

Rampelbergh, Jean Van, Peter Achenbach, Richard David Leslie, et al.. (2023). First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes. BMC Medicine. 21(1). 190–190. 13 indexed citations

Frères, Pierre, Stéphane Wenric, Corinne Fasquelle, et al.. (2015). Circulating microRNA-based screening tool for breast cancer. Oncotarget. 7(5). 5416–5428. 49 indexed citations

Bovy, Nicolas, Pierre Frères, Olivier Nivelles, et al.. (2015). Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget. 6(12). 10253–10266. 142 indexed citations

Valencia, Karmele, Diego Luis-Ravelo, Nicolas Bovy, et al.. (2014). miRNA cargo within exosome‐like vesicle transfer influences metastatic bone colonization. Molecular Oncology. 8(3). 689–703. 143 indexed citations

Frères, Pierre, Claire Josse, Nicolas Bovy, et al.. (2014). Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR‐34a and miR‐122 Expression. Journal of Cellular Physiology. 230(2). 473–481. 44 indexed citations

Frères, Pierre, et al.. (2014). 159 Neoadjuvant chemotherapy in breast cancer patients induces expression of miR-34a and miR-122. European Journal of Cancer. 50. 53–54. 3 indexed citations

Haghikia, Aiden, Edith Podewski, Elena Libhaber, et al.. (2013). Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Research in Cardiology. 108(4). 366–366. 219 indexed citations

Tabruyn, Sébastien P., Sylvain Hansen, Luisa Ojeda‐Fernández, et al.. (2013). MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells. Angiogenesis. 16(4). 877–887. 27 indexed citations

10.

Sabatel, Céline, Ludovic Malvaux, Nicolas Bovy, et al.. (2011). MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells. PLoS ONE. 6(2). e16979–e16979. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact